ITU Unit Action

REMIX

Remix Therapeutics Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88639146 FILING DATE 10/02/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY MUNN LEWIS, LAKEISHA S
L.O. ASSIGNED 105

PUB INFORMATION

RUN DATE 04/15/2022
PUB DATE 08/18/2020
STATUS 732-THIRD EXTENSION - GRANTED
STATUS DATE 04/13/2022
LITERAL MARK ELEMENT REMIX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT REMIX
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Remix Therapeutics Inc.
ADDRESS 400 Technology Square
Cambridge, MA 02139
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT pharmaceutical and therapeutic preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT pharmaceutical, medical, scientific, and biopharmaceutical research and development

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
04/15/2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 025
04/13/2022 EX3G S SOU EXTENSION 3 GRANTED 024
04/13/2022 EXT3 S SOU EXTENSION 3 FILED 023
04/13/2022 EEXT I TEAS EXTENSION RECEIVED 022
10/15/2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 021
10/13/2021 EX2G S SOU EXTENSION 2 GRANTED 020
10/13/2021 EXT2 S SOU EXTENSION 2 FILED 019
10/13/2021 EEXT I TEAS EXTENSION RECEIVED 018
04/10/2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 017
04/08/2021 EX1G S SOU EXTENSION 1 GRANTED 016
04/08/2021 EXT1 S SOU EXTENSION 1 FILED 015
04/08/2021 EEXT I TEAS EXTENSION RECEIVED 014
10/13/2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 013
08/18/2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 012
08/18/2020 PUBO A PUBLISHED FOR OPPOSITION 011
07/29/2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 010
07/16/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 009
06/23/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 008
06/23/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 007
06/23/2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 006
01/07/2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 005
01/07/2020 GNRT F NON-FINAL ACTION E-MAILED 004
01/07/2020 CNRT R NON-FINAL ACTION WRITTEN 003
01/07/2020 DOCK D ASSIGNED TO EXAMINER 002
10/05/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Christina M. Licursi, Esq.
CORRESPONDENCE ADDRESS Christina M. Licursi, Esq.
WOLF GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON MA 02210
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Remix Therapeutics Inc.
ADDRESS 400 Technology Square
Cambridge, MA 02139
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed